36 results
P
adolescent idiopathic scoliosis, AIS
I/C
body mass index, BMI, genetically decreased BMI
O
risk of AIS
P
ACS, ECG, AI
I/C
AI-based detection, case-control studies
O
accurate diagnosis and prompt treatment
P
acute ischemic stroke (AIS) patients
I/C
endovascular thrombectomy (EVT) and intravenous thrombolysis (IVT), early systolic blood pressure variability (SBPV) after EVT vs. IVT
O
functional outcome in AIS
P
patients with HCC
I/C
evaluation of HCC treatment using AI, evaluation without using AI
O
patient death and/or tumor recurrence
P
patients with ankle instability (AI)
I/C
case-control study, Patients with AI had a lower activation of peroneal muscles before landing
O
muscle activation of the lower extremity before landing
P
breast cancer survivors
I/C
aromatase inhibitor (AI), tamoxifen
O
cardiovascular disease (CVD), angina, stroke, myocardial infarction, venous thromboembolism, lipid profile changes
P
idiopathic short stature (ISS) children
I/C
monotherapy with AIs or GnRHa, placebo groups
O
final height
P
lung cancer patients
I/C
AI models, conventional methods
O
overall survival (OS), disease-free survival (DFS), progression-free survival (PFS), local control (LC)
P
burns patients
I/C
Artificial Intelligence (AI), current practices in burns care
O
accuracy of results
P
patients with cardiogenic shock (CS)
I/C
treatments for CS, patients with CS who underwent treatments for CS
O
prevalence of adrenal insufficiency (AI) in CS patients